InfuPharma Targets Insurer For Avastin Defense

Law360, New York (April 23, 2012, 7:54 PM EDT) -- InfuPharma LLC on Thursday dragged a Chartis Inc. affiliate into a dispute with another insurer over defense of the pharmaceutical distributor in suits alleging InfuPharma improperly compounded Genentech Inc.'s cancer drug Avastin, leading to eye injury and blindness.

In a third-party complaint filed in the Southern District of Florida, InfuPharma said Chartis affiliate Commerce and Industry Insurance Co. has a duty to defend it in the underlying suits under a policy that provides $2 million in coverage for "products completed operations" and another $2 million of...
To view the full article, register now.




Case Information

Case Title

Western Heritage Insurance Company v. InfuPharma, LLC et al

Case Number



Florida Southern

Nature of Suit



Federico A. Moreno

Date Filed

January 11, 2012

Law Firms


Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.